In our study, MMP9, a hub gene and upregulated DEG between uLMS-normal myometrium and uLMS-ULM cohorts, was part of the “negative regulation of apoptotic process” GO BP category, as well as “transcriptional misregulation in cancer” KEGG pathway enrichment. Here, MMP9 is linked to cancer.